Abstract
Experiments performed on rats have shown that a single intravenous injection of the antitumor preparations platidiam and pharmorubicine in the maximum tolerated dose cause morphological changes in the liver which are preserved for 3 months after platidiam and for 6 moths after pharmorubicine. Instability of reparative processes in the liver was revealed when the rats were poisoned with CCl4, 1, 3, and 6 months after administration of the cytostatics.
Similar content being viewed by others
References
G. G. Avtandilov,Medical Morphometry [in Russian], Moscow (1990).
L. M. Belen'kii, in:Elements of Quantitative Evaluation of Pharmacological Effect [in Russian], leningrad (1963), pp. 8–106.
I. D. Belyaeva and T. S. Ivleva,Byull. Eksp. Biol. Med.,87, No. 4, 374–349 (1979).
T. A. Bogush, E. V. Donenko, S. A. Gordeev,et al., Bioorg. Khimiya,11, No. 6, 853–855 (1985).
O. L. Voronova and V. E. Gol'dberg, in:Clinical and Experimental Parallels between Side Effect and Pharmacokinetics of Antitumor Preparations [in Russian], Tomsk, (1989), pp. 9–11.
M. L. Gershanovich,Complications of Chemo- and Hormone Therapies of Malignant Tumors [in Russian], Moscow (1982).
V. G. Kolb and V. S. Kamyshnikov,Manual of Clinical Chemistry [in Russian], Minsk (1982).
G. A. Merkulov,Pathohistological Techniques [in Russian], Leningrad (1969).
N. A. Dobbs, L. A. Summers, and C. J. Twelvesm,Br. J. Clin. Pharmacol.,30, No. 2, 324–325 (1990).
J. H. Doroshow and K. J. Davies,J. Biol. Chem.,261, No. 7, 3068–3074 (1986).
K. Mross, P. Maessen, W. Van der Vijgh,et al., J. Clin. Oncol.,6, No. 3, 517–526 (1988).
I. V. Uryvaeva,J. Theor. Biol.,89, No. 4, 557–571 (1981).
Author information
Authors and Affiliations
Additional information
Translated fromByulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 126, No. 11, pp. 561–564, November, 1998
Rights and permissions
About this article
Cite this article
Gol'dberg, E.D., Fomina, T.I., Vetoshkina, T.V. et al. Immediate and remote effects of antitumor drug on the morphology of rat liver. Bull Exp Biol Med 126, 1140–1143 (1998). https://doi.org/10.1007/BF02447256
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02447256